Oak Longevity Review 2026
Reviewed August 7, 2026 · Compounded semaglutide and tirzepatide only. Not FDA-approved.
Visit Oak Longevity WebsiteOverview
Oak Longevity sells compounded semaglutide from $119/month and compounded tirzepatide from $185/month, and its headline term is the most patient-friendly sentence we have read across this entire directory: 'One price · All dosages · No subscriptions.' Each of those three clauses closes a specific trap documented elsewhere in these reviews. One price, all dosages means your bill does not climb as you titrate to a therapeutic dose — the single most common way a cheap GLP-1 programme becomes an expensive one. No subscriptions means there is no auto-renewal, no 21-day billing cycle, no two-month minimum and no 72-hour cancellation deadline to miss — which between them account for the majority of billing complaints we found against competitors in this queue. Free shipping and free health coaching are included, and the site publishes a comparison tool and a cost calculator rather than asking you to take its pricing on trust. It claims more than 10,000 satisfied patients. The reservations are modest. 'Up to 50% cheaper than competitors' is a comparative claim with no methodology or comparison set behind it, and on the figures in this directory it is not obviously true — Ozari at $86 and Sunlight at $88 both undercut Oak's $119 semaglutide. The catalogue is compounded only, with no FDA-approved route, and the usual disclosures are missing: no named pharmacy, no eligibility criteria, no lab requirements, no state list and no refund policy.
Medications Offered
Brand-name or compounded: Compounded semaglutide and tirzepatide only. Not FDA-approved.
- Compounded semaglutide — as low as $119/month, all dosages at one price
- Compounded tirzepatide — as low as $185/month, all dosages at one price
- Free health coaching included
- Multi-month bundle figures observed at $400, $500, $1,000 and $1,400
- No brand-name or FDA-approved option offered
Consultation Process
See if you qualify
Oak runs an online qualification flow. No BMI threshold or eligibility criteria is published in advance.
Provider review
A provider reviews your information and prescribes if appropriate. Free health coaching is included alongside medication.
One price, no subscription
You pay per order rather than entering a subscription. There is no recurring billing to cancel and no dose-based price increase to plan for.
Free shipping and refills
Shipping is free and the site provides a refill route. Because there is no subscription, refills are initiated by you rather than billed automatically.
Eligibility
- Adults; no published BMI threshold or age range
- Provider approval required
- No insurance required — cash-pay
- State availability is not published
- Standard GLP-1 contraindications apply
Provider Involvement
Free health coaching is included alongside the prescription, which is more support than most providers at this price point bundle. Beyond that, no named clinical leadership, monitoring cadence or lab protocol is published. The no-subscription model does mean you actively decide to reorder each time rather than drifting on autopilot, which is arguably better for treatment engagement as well as for your wallet.
Lab Requirements
Not published. Ask what baseline monitoring is expected before starting.
Pharmacy Fulfillment
Not named. Oak does not identify its compounding pharmacy or state its 503A or 503B status. Ask before ordering.
Shipping Frequency
Free shipping included. Because there is no subscription, shipments follow your orders rather than an automatic cadence.
Membership Fees vs. Medication Fees
Membership fees
None. Oak explicitly advertises 'No subscriptions', so there is no membership, platform or recurring fee.
Medication fees
- Compounded semaglutide: as low as $119/month, all dosages
- Compounded tirzepatide: as low as $185/month, all dosages
- Shipping and health coaching: included
- Multi-month bundle totals observed at $400, $500, $1,000 and $1,400
Cancellation & Refund Policy
Cancellation
Effectively not required, which is the point. Oak states 'No subscriptions', so there is no recurring charge to cancel, no renewal date to diarise and no notice period to miss. Against a market where auto-renewal, 21-day billing cycles, two-month minimums and 72-hour cancellation cutoffs generate most complaints, this structure removes the problem rather than disclosing it.
Refunds
Not published on the pages we reviewed. Ask what happens if you are dispensed medication you cannot tolerate.
Insurance
Not offered. Oak is cash-pay and compounded only. If you have GLP-1 coverage, a brand-name provider will almost certainly cost less.
HSA / FSA
Not stated. Confirm directly.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- Free health coaching
- Free shipping
- Published comparison tool and cost calculator
- Self-service refill route
State Availability
Not published. Confirm your state before starting.
Pros
- 'One price · All dosages · No subscriptions' — the clearest anti-escalation, anti-lock-in statement in this directory
- Compounded semaglutide from $119/month and tirzepatide from $185/month
- No subscription at all, so there is no auto-renewal and no cancellation deadline to miss
- Free shipping and free health coaching included
- Publishes a comparison tool and a cost calculator
- Claims 10,000+ satisfied patients
Cons
- 'Up to 50% cheaper than competitors' is a comparative claim with no basis shown
- Compounded only — no brand-name or FDA-approved route
- No named compounding pharmacy
- No published BMI criteria, eligibility rules, lab requirements or state list
- No published refund policy
- Limited independent review record to corroborate the patient count
Who Oak Longevity May Be Best For
- Anyone who has been burned by auto-renewal or dose-based price increases elsewhere
- Cash-pay patients who expect to titrate to a higher dose
- People who want to buy per order rather than commit to a recurring plan
Limitations
- Compounded only, with no FDA-approved or insurance route
- Unsubstantiated '50% cheaper' comparative claim
- No named pharmacy, eligibility criteria, labs, states or refund policy
- Not the outright cheapest despite the claim
Reputation & Trust
Oak's commercial structure is the best-designed we have encountered in this directory, and the reason is that it eliminates rather than discloses the two biggest traps in this market. Dose-based price escalation is the main mechanism by which a $99 headline becomes a $400 bill; Oak charges one price for all dosages. Auto-renewal with a short cancellation window is the main source of billing complaints — WellMedr's 21-day cycle, Shed's two-month minimum and 72-hour cutoff, Ro's contact-support-only cancellation; Oak has no subscription at all, so there is nothing to renew and nothing to cancel. Free shipping, free health coaching, a published comparison tool and a cost calculator all point the same way. The claims that do not hold up as well are the promotional ones. 'Up to 50% cheaper than competitors' has no methodology attached and is not obviously true on the numbers in this directory — Ozari at $86/month and Sunlight at $88/month both come in below Oak's $119 semaglutide, though neither matches Oak's no-subscription structure. The 10,000-patient figure is unverifiable. And the usual disclosure gaps apply: no named pharmacy, no eligibility criteria, no lab requirements, no state list, no refund policy.
What Makes Oak Longevity Different
- One price across all dosages — no escalation as you titrate
- No subscription, so no auto-renewal and no cancellation deadline
- Free health coaching bundled with medication
- Published comparison tool and cost calculator
Our Verdict
Oak Longevity earns 4/5 for having the best-designed commercial structure in this directory. 'One price · All dosages · No subscriptions' is three sentences that between them eliminate the two mechanisms responsible for most of the consumer harm documented across these reviews: dose-based price escalation, which turns a cheap headline into an expensive maintenance bill, and auto-renewal with a short cancellation window, which is behind the billing complaints at nearly every competitor we examined in this queue — the 21-day billing cycle at one, the two-month minimum and 72-hour cutoff at another, the contact-support-only cancellation at a third. Oak simply does not have those problems, because there is nothing recurring to cancel and no dose band to climb. Add free shipping, free health coaching, a published comparison tool and a cost calculator, and the proposition is genuinely well made at $119 semaglutide and $185 tirzepatide. What stops it scoring higher is that it is compounded-only with no FDA-approved route, its 'up to 50% cheaper than competitors' claim is unsubstantiated and does not survive comparison with Ozari or Sunlight, and it publishes no pharmacy name, eligibility criteria, lab requirements, state list or refund policy. Ask those questions; the structure is worth it.
Alternatives to Oak Longevity
Cheaper at $86/month with 50-state coverage, though without Oak's no-subscription structure.
Also flat dose-independent pricing, with published state exclusions and cancellation contacts.
Comparable pricing with far more published about regulatory status and billing terms.
If you have insurance, a full formulary with brand-name options and the clearest disclosure here.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
Does Oak's price really cover all doses?
That is what it states: 'One price · All dosages · No subscriptions', with compounded semaglutide as low as $119/month and tirzepatide as low as $185/month. If it holds, it is worth more than a lower headline rate from a provider that re-bands you upward at 10mg — dose escalation is how most cheap GLP-1 programmes become expensive ones. Get it confirmed in writing at your first order.
Is there really no subscription?
Oak advertises 'No subscriptions', meaning you order rather than enrol. That removes auto-renewal, renewal dates, notice periods and cancellation deadlines — collectively the largest source of complaints against providers in this directory, including 21-day billing cycles and 72-hour cancellation cutoffs found elsewhere in this same queue. It is the single most consumer-friendly structure we have reviewed.
Is Oak really 50% cheaper than competitors?
We would not rely on that claim. It is published with no methodology or comparison set, and on the pricing in this directory it does not clearly hold — Ozari Health at $86/month and Sunlight at $88/month both undercut Oak's $119 semaglutide. Where Oak genuinely wins is structure rather than headline price: one price for all doses, and no subscription at all.
Is Oak's medication FDA-approved?
No. Oak sells compounded semaglutide and tirzepatide, which are not FDA-approved, have not been evaluated for safety, efficacy or quality, and are not therapeutically equivalent to Wegovy, Ozempic, Mounjaro or Zepbound beyond the shared active ingredient. There is no brand-name option here.
Important Notes & Warnings
- This review is informational only and is not medical advice. Consult a licensed clinician before starting or changing treatment.
- Compounded semaglutide and tirzepatide are NOT FDA-approved and are not therapeutically equivalent to Wegovy, Ozempic, Mounjaro or Zepbound beyond the shared active ingredient.
- 'Up to 50% cheaper than competitors' is published without methodology and is not clearly accurate against the pricing in this directory.
- No compounding pharmacy is named — ask which facility fills your prescription and its 503A status.
- No refund policy, eligibility criteria, lab requirements or state list is published.
- GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2, and in pregnancy.
- Common side effects include nausea, vomiting, diarrhoea, constipation and abdominal pain; serious risks include pancreatitis, gallbladder disease and kidney injury from dehydration.
Sources
- Oak Longevity weight-loss and pricing pages, oaklovesyou.com (accessed 7 August 2026)
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 7, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.